Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Dad's gentle touch may boost newborn health in first hours of life

NCT ID NCT07302412

Symptom relief Sponsor: Acibadem University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether gentle touch from a father can improve sucking, comfort, and blood sugar levels in newborns at risk for hypoglycemia. About 98 babies will be randomly assigned to receive either routine care or 15-minute gentle touch sessions from their father every hour for the first 6 hours of life. Researchers will measure comfort, breastfeeding success, and glucose levels to see if this simple, non-invasive approach makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Gentle Human Touch (a procedure where the father places warm, steady hands on the newborn's head and pelvis for 15 minutes, repeated hourly for 6 hours)
What this could lead to
If it works, this could offer a simple, non-invasive way to support newborns at risk for low blood sugar, improving their comfort and feeding success without medication.
What could go wrong
This is a small, early-stage trial with only 98 participants, so results may not apply to all newborns. The effect of touch may be too subtle to produce clear benefits, and the study does not test long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 98 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 hour to 6 hours

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Newborns identified as being at risk for hypoglycemia (see study population). * Newborns whose parents/legal guardians have provided written informed consent. * Clinically stable newborns who have no contraindications to breastfeeding during the first 6 hours after birth. * Newborns whose fathers are present during the first 6 hours after birth. Exclusion Criteria: * Newborns who develop hypoglycemia during the study period or who require initiation of hypoglycemia treatment. * Newborns with congenital anomalies or a diagnosed genetic syndrome.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant, newborn are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant, newborn

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Acibadem University Atakent Hospital

    RECRUITING

    Istanbul, Istanbul, 34260, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.